Innate Immunotherapeutics

9 articles about Innate Immunotherapeutics

• 

  Former Innate Immunotherapeutics Board Member Chris Collins Expected to Plead...

  10/1/2019

  On Monday, the House Republican resigned his congressional seat ahead of the expected plea.
• 

  SEC Aims Insider Trading Charges at Former Sangamo Therapeutics Executive

  8/24/2018

  The U.S. Securities and Exchange Commission has leveled charges at a former Sangamo Therapeutics Inc. executive and others for an insider-trading scheme that netted more than $1.5 million in “illegal profits.”
• 

  U.S. Rep. Chris Collins, an Innate Immunotherapeutics Board Member, Charged With Insider Trading

  8/8/2018

  A New York Republican Congressman and his son have been charged with insider trading. U.S. Rep. Chris Collins was a board member for Australia-based Innate Immunotherapeutics. The government charged he used that information to help his son make timely trades.

• Innate Immunotherapeutics Release: Multiple Abstracts Concerning MIS416 Mechanism Of Action Accepted For Presentation At Upcoming American Academy Of Neurologists Meeting

  3/7/2017

• Questions Arise Over a Congressman's Ties With Australian Biotech Innate Immunotherapeutics

  2/20/2017

• Innate Immunotherapeutics Announces Clinical Trial Fully Enrolled And Receives Strong Interest From Potential Pharma Partners

  4/13/2016

• Innate Immunotherapeutics’s Phase 2B Clinical Trial On SPMS To Start Recruiting Patients Following Perth Site Obtaining Ethics Approval

  8/19/2014

• Innate Immunotherapeutics Completes $10 Million IPO

  12/18/2013

• Innate Immunotherapeutics Launches IPO To Raise Up To A$12 Million

  11/27/2013